> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Loper Bright May End FDA Speech Ban: Attorney
- URL: https://www.fdaweb.com/loper-bright-may-end-fda-speech-ban-attorney/
- Published: 2024-08-06T12:00:00.000Z
- Updated: 2026-09-14T14:37:30.000Z
- Author: David McFarland
- Tags: Drugs, Devices, #legacy-id-D5157516

Attorney **James Beck** (Reed Smith) says the Supreme Court decision in *Loper Bright* overturning judicial deference to administrative agencies could lead to significant changes to FDA’s ban on off-label speech. Writing online in the *Drug and Device Law Blog*, Beck [says](https://www.druganddevicelawblog.com/2024/08/could-loper-bright-finally-do-in-fdas-rickety-off-label-speech-ban.html?ref=fdaweb.com) FDA has been relying on a “very suspect assemblage of statutory and regulatory provisions that don’t really fit together to create such a sweeping ban,” especially since nothing in the Federal Food, Drug, and Cosmetic Act (FFDCA) specifically bans the promotion or marketing of drugs for off-label use.

Since *Loper Bright* essentially tells courts to ignore administrative interpretations of unclear laws and instead give statutes “the reading the court would have reached if no agency were involved,” Beck says it is unlikely that the best reading of the FFDCA is a nearly complete ban on off-label speech without regard to truth or scientific merit.

He also points to another recent Supreme Court decision that the Administrative Procedure Act statute of limitations runs from whenever a plaintiff is actually injured as leading to a *Loper Bright* challenge to the basis for a ban on off-label speech whenever a plaintiff is injured by a new application of the ban. There are pending off-label speech guidances on “misinformation” and “communication with healthcare providers” that could lead to such a challenge, he writes.